Scheduled to open in the first half of 2024,
Lilly's new Gateway Labs location, in partnership with Alexandria
Real Estate Equities, will feature a world-class, state-of-the-art
lab facility to support early-stage scientific entrepreneurs and
companies
INDIANAPOLIS, Nov. 28,
2023 /PRNewswire/ -- Eli Lilly and Company (NYSE:
LLY) today announced plans to open its first-ever Lilly
Gateway Labs location in San Diego,
Calif. in the first half of 2024. Gateway Labs is Lilly's
shared innovation accelerator that provides participating companies
with state-of-the-art lab space and unique access to Lilly
scientists, researchers and executives, as well as exposure to
Lilly's functional and scientific expertise. This will be the
company's third Gateway Labs location, with additional sites
located in San Francisco and
Boston.
"We are excited to expand our footprint in San Diego as it is home to a thriving life
sciences community," said Daniel
Skovronsky, M.D., Ph.D., chief scientific officer, and
president, Lilly Research Laboratories. "By providing lab space and
access to Lilly's scientific expertise, we can support scientists
from research institutes, universities and small biotech companies
as they work to discover the next generation of medicines for
patients."
Companies located at Gateway Labs have the opportunity to
collaborate with Lilly and each other on research of mutual
interest, participate in shared learning and scientific symposia
with Lilly experts and partners, and have the potential for
financial investment directly from Lilly, venture capital funds, or
both. In partnership with Alexandria Real Estate Equities Inc.
(ARE), the new site will merge Lilly's scientific expertise with
ARE's operational excellence to create a world-class facility.
The new site will be located in Alexandria's University Town Center (UTC)
campus, and offer nearly 62,000 square feet of rentable,
flexibly-designed lab space, as well as open workstations for
fostering scientific exchange and collaboration among participating
companies. It is expected to accommodate 10 companies and
more than 120 biotech and Lilly employees.
"Lilly has been supporting early-phase external innovation for
decades, and we are excited to continue to expand our Gateway Labs
shared innovation spaces to a larger network of life science
startups" said Julie Gilmore, Ph.D.,
vice president, and global head of Gateway Labs. "The expansion of
our Gateway Labs model will grant scientists access to Lilly's
research operations, mentorship and expertise in an environment
made to foster scientific breakthroughs."
Companies interested in joining Lilly Gateway Labs should visit
www.gatewaylabs.lilly.com and contact GatewayLabs@lilly.com.
About Lilly
Lilly unites caring with discovery to create medicines that make
life better for people around the world. We've been pioneering
life-changing discoveries for nearly 150 years, and today our
medicines help more than 51 million people across the globe.
Harnessing the power of biotechnology, chemistry and genetic
medicine, our scientists are urgently advancing new discoveries to
solve some of the world's most significant health challenges,
redefining diabetes care, treating obesity and curtailing its most
devastating long-term effects, advancing the fight against
Alzheimer's disease, providing solutions to some of the most
debilitating immune system disorders, and transforming the most
difficult-to-treat cancers into manageable diseases. With each step
toward a healthier world, we're motivated by one thing: making life
better for millions more people. That includes delivering
innovative clinical trials that reflect the diversity of our world
and working to ensure our medicines are accessible and affordable.
To learn more, visit Lilly.com and Lilly.com/news or
follow us on Facebook, Instagram and LinkedIn. C-LLY
Refer
to:
|
Stefanie Prodouz;
stefanie.prodouz@lilly.com; +1-317-287-9899 (Media)
|
|
Joe
Fletcher; jfletcher@lilly.com; +1-317-296-2884
(Investors)
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lilly-announces-plans-to-open-its-first-ever-gateway-labs-site-in-san-diego-301998388.html
SOURCE Eli Lilly and Company